Autolus Therapeutics plc American Depositary Receipt (AUTL) at a glance

Autolus Therapeutics plc American Depositary Receipt (AUTL) is a small-cap Healthcare company. It trades at $2.33, with a -27.8% profit margin and revenue growth of 7.9%. It does not pay a dividend. Vestovix scores it 60/100 overall. Its strongest dimension is Growth (80/100) and its weakest is Income (40/100).

Price

$2.34

Market cap

$415.2M

P/E ratio

n/a

Dividend yield

None

Beta

n/a

52-week range

$1.18 to $2.58